Plasma levels of some blood coagulation parameters in Nigerian homozygous sickle cell patients (HbSS) in steady state

The plasma levels of some blood coagulation parameters; prothrombin time, (PT), partial thromboplastin time with kaolin (PTTK), thrombin clotting time, (TCT), fibrinogen and factor X assay were determined in 50 Nigerian homozygous (HbSS) patients and 50 HbAA healthy individuals for the purpose of as...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hematology (Luxembourg) 2006-10, Vol.11 (5-6), p.375-379
Hauptverfasser: Buseri, Fiekumo I., Jeremiah, Zaccheaus A., Shokunbi, Wuraola A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 379
container_issue 5-6
container_start_page 375
container_title Hematology (Luxembourg)
container_volume 11
creator Buseri, Fiekumo I.
Jeremiah, Zaccheaus A.
Shokunbi, Wuraola A.
description The plasma levels of some blood coagulation parameters; prothrombin time, (PT), partial thromboplastin time with kaolin (PTTK), thrombin clotting time, (TCT), fibrinogen and factor X assay were determined in 50 Nigerian homozygous (HbSS) patients and 50 HbAA healthy individuals for the purpose of assessing their baseline values and susceptibility of patients with sickle cell disease (SCD) to hyper coagulability. Standard procedures were used for all variables. The mean age of the study participants was 21.7 ± 5.0 years. The mean PT of 13.7 ± 1.4s in HbSS patients was found to be significantly longer than the mean PT value of 12.9 ± 1.0 in HbAA control subjects (p < 0.001). The mean PTTK values of 46.0 ± 9.6s in HbSS patients was also found to be significantly higher than the 41.0 ± 3.7s recorded among the control subjects (p < 0.001). The mean TCT of 6.4 ± 0.8s in HbSS patients was however found to be significantly lower than the mean value of 10.6 ± 0.8s obtained in the control group. Fibrinogen level (4.1 ± 2.1 g/l) in HbSS patients and 2.8 ± 0.9 g/l in HbAA controls was also found to be significantly different (p < 0.001). Factor X level in the sickle cell patients, (64.6 ± 14.9%) was equally found to be significantly lower than that of the apparently healthy HbAA control individuals (95.2 ± 7.2%) (p < 0.001).
doi_str_mv 10.1080/10245330600841287
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_17607590</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68341862</sourcerecordid><originalsourceid>FETCH-LOGICAL-c395t-8a0850d5d8f010a5a4f52c408bd3aa44ef36ea00979a9d7797977f51aee2f2f83</originalsourceid><addsrcrecordid>eNp1kF9LHDEUxUOx1D_tB-iL5En0YdubmWSSAV9EtBZEC7bPw92ZmzWamaxJpmX76Z1lFxTEp3Ph_s7hcBj7KuCbAAPfBRRSlSVUAEaKwugPbE9UoGdGKrnz6t5l-yk9ABQFaPjEdoWePqqGPTb-8ph65J7-kk88WJ5CT3zuQ-h4G3AxeswuDHyJEXvKFBN3A79xC4oOB34f-vB_tQhj4sm1j554S95PdHY05MSPr-Z3dydrS8qE3WoSzPSZfbToE33Z6gH7c3nx-_xqdn374-f52fWsLWuVZwbBKOhUZywIQIXSqqKVYOZdiSgl2bIiBKh1jXWn9aRaWyWQqLCFNeUBO9rkLmN4GinlpndpXRAHmio3lSmlMFUxgWIDtjGkFMk2y-h6jKtGQLPeunmz9eQ53IaP8566F8d23Ak43QBusCH2-C9E3zUZVz5EG3FoXWrK9_OfATpTjVQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68341862</pqid></control><display><type>article</type><title>Plasma levels of some blood coagulation parameters in Nigerian homozygous sickle cell patients (HbSS) in steady state</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Buseri, Fiekumo I. ; Jeremiah, Zaccheaus A. ; Shokunbi, Wuraola A.</creator><creatorcontrib>Buseri, Fiekumo I. ; Jeremiah, Zaccheaus A. ; Shokunbi, Wuraola A.</creatorcontrib><description>The plasma levels of some blood coagulation parameters; prothrombin time, (PT), partial thromboplastin time with kaolin (PTTK), thrombin clotting time, (TCT), fibrinogen and factor X assay were determined in 50 Nigerian homozygous (HbSS) patients and 50 HbAA healthy individuals for the purpose of assessing their baseline values and susceptibility of patients with sickle cell disease (SCD) to hyper coagulability. Standard procedures were used for all variables. The mean age of the study participants was 21.7 ± 5.0 years. The mean PT of 13.7 ± 1.4s in HbSS patients was found to be significantly longer than the mean PT value of 12.9 ± 1.0 in HbAA control subjects (p &lt; 0.001). The mean PTTK values of 46.0 ± 9.6s in HbSS patients was also found to be significantly higher than the 41.0 ± 3.7s recorded among the control subjects (p &lt; 0.001). The mean TCT of 6.4 ± 0.8s in HbSS patients was however found to be significantly lower than the mean value of 10.6 ± 0.8s obtained in the control group. Fibrinogen level (4.1 ± 2.1 g/l) in HbSS patients and 2.8 ± 0.9 g/l in HbAA controls was also found to be significantly different (p &lt; 0.001). Factor X level in the sickle cell patients, (64.6 ± 14.9%) was equally found to be significantly lower than that of the apparently healthy HbAA control individuals (95.2 ± 7.2%) (p &lt; 0.001).</description><identifier>ISSN: 1607-8454</identifier><identifier>EISSN: 1607-8454</identifier><identifier>DOI: 10.1080/10245330600841287</identifier><identifier>PMID: 17607590</identifier><language>eng</language><publisher>England: Taylor &amp; Francis</publisher><subject>Adolescent ; Adult ; Anemia, Sickle Cell - blood ; Anemia, Sickle Cell - complications ; Blood Coagulation Factors - analysis ; Blood Coagulation Tests ; Case-Control Studies ; FACTOR X ; Factor Xa - analysis ; Factor Xa - metabolism ; Female ; FIBRINOGEN ; Fibrinogen - analysis ; HBSS ; Homozygote ; Humans ; Male ; NIGERIA ; PROTHROMBIN TIME ; THROMBIN CLOTTING TIME ; Thrombophilia - diagnosis</subject><ispartof>Hematology (Luxembourg), 2006-10, Vol.11 (5-6), p.375-379</ispartof><rights>2006 Maney Publishing 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c395t-8a0850d5d8f010a5a4f52c408bd3aa44ef36ea00979a9d7797977f51aee2f2f83</citedby><cites>FETCH-LOGICAL-c395t-8a0850d5d8f010a5a4f52c408bd3aa44ef36ea00979a9d7797977f51aee2f2f83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17607590$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Buseri, Fiekumo I.</creatorcontrib><creatorcontrib>Jeremiah, Zaccheaus A.</creatorcontrib><creatorcontrib>Shokunbi, Wuraola A.</creatorcontrib><title>Plasma levels of some blood coagulation parameters in Nigerian homozygous sickle cell patients (HbSS) in steady state</title><title>Hematology (Luxembourg)</title><addtitle>Hematology</addtitle><description>The plasma levels of some blood coagulation parameters; prothrombin time, (PT), partial thromboplastin time with kaolin (PTTK), thrombin clotting time, (TCT), fibrinogen and factor X assay were determined in 50 Nigerian homozygous (HbSS) patients and 50 HbAA healthy individuals for the purpose of assessing their baseline values and susceptibility of patients with sickle cell disease (SCD) to hyper coagulability. Standard procedures were used for all variables. The mean age of the study participants was 21.7 ± 5.0 years. The mean PT of 13.7 ± 1.4s in HbSS patients was found to be significantly longer than the mean PT value of 12.9 ± 1.0 in HbAA control subjects (p &lt; 0.001). The mean PTTK values of 46.0 ± 9.6s in HbSS patients was also found to be significantly higher than the 41.0 ± 3.7s recorded among the control subjects (p &lt; 0.001). The mean TCT of 6.4 ± 0.8s in HbSS patients was however found to be significantly lower than the mean value of 10.6 ± 0.8s obtained in the control group. Fibrinogen level (4.1 ± 2.1 g/l) in HbSS patients and 2.8 ± 0.9 g/l in HbAA controls was also found to be significantly different (p &lt; 0.001). Factor X level in the sickle cell patients, (64.6 ± 14.9%) was equally found to be significantly lower than that of the apparently healthy HbAA control individuals (95.2 ± 7.2%) (p &lt; 0.001).</description><subject>Adolescent</subject><subject>Adult</subject><subject>Anemia, Sickle Cell - blood</subject><subject>Anemia, Sickle Cell - complications</subject><subject>Blood Coagulation Factors - analysis</subject><subject>Blood Coagulation Tests</subject><subject>Case-Control Studies</subject><subject>FACTOR X</subject><subject>Factor Xa - analysis</subject><subject>Factor Xa - metabolism</subject><subject>Female</subject><subject>FIBRINOGEN</subject><subject>Fibrinogen - analysis</subject><subject>HBSS</subject><subject>Homozygote</subject><subject>Humans</subject><subject>Male</subject><subject>NIGERIA</subject><subject>PROTHROMBIN TIME</subject><subject>THROMBIN CLOTTING TIME</subject><subject>Thrombophilia - diagnosis</subject><issn>1607-8454</issn><issn>1607-8454</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kF9LHDEUxUOx1D_tB-iL5En0YdubmWSSAV9EtBZEC7bPw92ZmzWamaxJpmX76Z1lFxTEp3Ph_s7hcBj7KuCbAAPfBRRSlSVUAEaKwugPbE9UoGdGKrnz6t5l-yk9ABQFaPjEdoWePqqGPTb-8ph65J7-kk88WJ5CT3zuQ-h4G3AxeswuDHyJEXvKFBN3A79xC4oOB34f-vB_tQhj4sm1j554S95PdHY05MSPr-Z3dydrS8qE3WoSzPSZfbToE33Z6gH7c3nx-_xqdn374-f52fWsLWuVZwbBKOhUZywIQIXSqqKVYOZdiSgl2bIiBKh1jXWn9aRaWyWQqLCFNeUBO9rkLmN4GinlpndpXRAHmio3lSmlMFUxgWIDtjGkFMk2y-h6jKtGQLPeunmz9eQ53IaP8566F8d23Ak43QBusCH2-C9E3zUZVz5EG3FoXWrK9_OfATpTjVQ</recordid><startdate>20061001</startdate><enddate>20061001</enddate><creator>Buseri, Fiekumo I.</creator><creator>Jeremiah, Zaccheaus A.</creator><creator>Shokunbi, Wuraola A.</creator><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20061001</creationdate><title>Plasma levels of some blood coagulation parameters in Nigerian homozygous sickle cell patients (HbSS) in steady state</title><author>Buseri, Fiekumo I. ; Jeremiah, Zaccheaus A. ; Shokunbi, Wuraola A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c395t-8a0850d5d8f010a5a4f52c408bd3aa44ef36ea00979a9d7797977f51aee2f2f83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Anemia, Sickle Cell - blood</topic><topic>Anemia, Sickle Cell - complications</topic><topic>Blood Coagulation Factors - analysis</topic><topic>Blood Coagulation Tests</topic><topic>Case-Control Studies</topic><topic>FACTOR X</topic><topic>Factor Xa - analysis</topic><topic>Factor Xa - metabolism</topic><topic>Female</topic><topic>FIBRINOGEN</topic><topic>Fibrinogen - analysis</topic><topic>HBSS</topic><topic>Homozygote</topic><topic>Humans</topic><topic>Male</topic><topic>NIGERIA</topic><topic>PROTHROMBIN TIME</topic><topic>THROMBIN CLOTTING TIME</topic><topic>Thrombophilia - diagnosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Buseri, Fiekumo I.</creatorcontrib><creatorcontrib>Jeremiah, Zaccheaus A.</creatorcontrib><creatorcontrib>Shokunbi, Wuraola A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Hematology (Luxembourg)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Buseri, Fiekumo I.</au><au>Jeremiah, Zaccheaus A.</au><au>Shokunbi, Wuraola A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasma levels of some blood coagulation parameters in Nigerian homozygous sickle cell patients (HbSS) in steady state</atitle><jtitle>Hematology (Luxembourg)</jtitle><addtitle>Hematology</addtitle><date>2006-10-01</date><risdate>2006</risdate><volume>11</volume><issue>5-6</issue><spage>375</spage><epage>379</epage><pages>375-379</pages><issn>1607-8454</issn><eissn>1607-8454</eissn><abstract>The plasma levels of some blood coagulation parameters; prothrombin time, (PT), partial thromboplastin time with kaolin (PTTK), thrombin clotting time, (TCT), fibrinogen and factor X assay were determined in 50 Nigerian homozygous (HbSS) patients and 50 HbAA healthy individuals for the purpose of assessing their baseline values and susceptibility of patients with sickle cell disease (SCD) to hyper coagulability. Standard procedures were used for all variables. The mean age of the study participants was 21.7 ± 5.0 years. The mean PT of 13.7 ± 1.4s in HbSS patients was found to be significantly longer than the mean PT value of 12.9 ± 1.0 in HbAA control subjects (p &lt; 0.001). The mean PTTK values of 46.0 ± 9.6s in HbSS patients was also found to be significantly higher than the 41.0 ± 3.7s recorded among the control subjects (p &lt; 0.001). The mean TCT of 6.4 ± 0.8s in HbSS patients was however found to be significantly lower than the mean value of 10.6 ± 0.8s obtained in the control group. Fibrinogen level (4.1 ± 2.1 g/l) in HbSS patients and 2.8 ± 0.9 g/l in HbAA controls was also found to be significantly different (p &lt; 0.001). Factor X level in the sickle cell patients, (64.6 ± 14.9%) was equally found to be significantly lower than that of the apparently healthy HbAA control individuals (95.2 ± 7.2%) (p &lt; 0.001).</abstract><cop>England</cop><pub>Taylor &amp; Francis</pub><pmid>17607590</pmid><doi>10.1080/10245330600841287</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1607-8454
ispartof Hematology (Luxembourg), 2006-10, Vol.11 (5-6), p.375-379
issn 1607-8454
1607-8454
language eng
recordid cdi_pubmed_primary_17607590
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Adolescent
Adult
Anemia, Sickle Cell - blood
Anemia, Sickle Cell - complications
Blood Coagulation Factors - analysis
Blood Coagulation Tests
Case-Control Studies
FACTOR X
Factor Xa - analysis
Factor Xa - metabolism
Female
FIBRINOGEN
Fibrinogen - analysis
HBSS
Homozygote
Humans
Male
NIGERIA
PROTHROMBIN TIME
THROMBIN CLOTTING TIME
Thrombophilia - diagnosis
title Plasma levels of some blood coagulation parameters in Nigerian homozygous sickle cell patients (HbSS) in steady state
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T16%3A51%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasma%20levels%20of%20some%20blood%20coagulation%20parameters%20in%20Nigerian%20homozygous%20sickle%20cell%20patients%20(HbSS)%20in%20steady%20state&rft.jtitle=Hematology%20(Luxembourg)&rft.au=Buseri,%20Fiekumo%20I.&rft.date=2006-10-01&rft.volume=11&rft.issue=5-6&rft.spage=375&rft.epage=379&rft.pages=375-379&rft.issn=1607-8454&rft.eissn=1607-8454&rft_id=info:doi/10.1080/10245330600841287&rft_dat=%3Cproquest_pubme%3E68341862%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68341862&rft_id=info:pmid/17607590&rfr_iscdi=true